Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (UH 270/2-1; AOBJ: 674373)
Received: 9 January 2022
Accepted: 17 April 2022
First Online: 12 May 2022
: The study protocol, patient information and consent are approved by the ethics committee of the university of Heidelberg (S-227/2018). Furthermore, the trial is approved by the German Federal Office for Radiation Protection (Bundesamt fuer Strahlenschutz) (Z5-22461/2-2018-004). Written informed consent will be obtained from all study participants.
: No individual person’s data is used in the manuscript.
: The authors declare that they have no competing interests.